Levopropylhexedrine
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Ffffrr (talk | contribs) at 12:47, 1 August 2022 (Importing Wikidata short description: "Chemical compound"). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 12:47, 1 August 2022 by Ffffrr (talk | contribs) (Importing Wikidata short description: "Chemical compound")
Chemical compound
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.025.678 |
Chemical and physical data | |
Formula | C10H21N |
Molar mass | 155.285 g·mol−1 |
3D model (JSmol) | |
|
Levopropylhexedrine (Eventin) is a psychostimulant used as an anorectic in Germany[1][2] and patented by Smith Kline & French in 1947.[3] It has also been used in the anticonvulsant preparation barbexaclone in combination with phenobarbital to offset sedation.[4][5][6] Levopropylhexedrine is the S-enantiomer of propylhexedrine.
See also
References
- ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ^ Hofer R, Locker A (1958). "Über therapeutische Erfahrungen mit dem Appetitzügler Eventin" [Therapeutic experiences with the appetite depressant eventin]. Wiener Medizinische Wochenschrift (in German). 108 (14): 304–6. PMID 13558159.
- ^ US 2454746 Cyclohexylalkylamines
- ^ Oliveira C, Fernandes I, De Lima JM, Musse R (1977). "Ensaio clínico com barbexaclone nas epilepsias" [Clinical trial with barbexaclone in epilepsies]. Arquivos de Neuro-Psiquiatria (in Portuguese). 35 (1): 68–72. doi:10.1590/s0004-282x1977000100008. PMID 14606.
- ^ Iven H, Feldbusch E (1983). "Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (2): 153–9. doi:10.1007/bf00497022. PMID 6139756. S2CID 25628466.
- ^ Seyffart, G. (1991). Drug dosage in renal insufficiency. Boston: Kluwer Academic Publishers. ISBN 0-7923-0964-2.
DRAsTooltip Dopamine releasing agents |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAsTooltip Norepinephrine releasing agents |
| ||||||||||||||
SRAsTooltip Serotonin releasing agents |
| ||||||||||||||
Others |
| ||||||||||||||
Hidden categories:
- CS1 German-language sources (de)
- CS1 Portuguese-language sources (pt)
- Redirects with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles containing unverified chemical infoboxes
- Redirects connected to a Wikidata item